litlas
ログインアカウント作成

Paul E. Sax

1995–2025 年に発表

110
論文数
20,190
被引用数
73
h 指数
106
i10 指数

被引用数

Paul E. Sax の年別被引用数1998 年: 被引用 30 件1999 年: 被引用 58 件2000 年: 被引用 60 件2001 年: 被引用 96 件2002 年: 被引用 91 件2003 年: 被引用 94 件2004 年: 被引用 73 件2005 年: 被引用 83 件2006 年: 被引用 85 件2007 年: 被引用 73 件2008 年: 被引用 86 件2009 年: 被引用 77 件2010 年: 被引用 91 件2011 年: 被引用 92 件2012 年: 被引用 107 件2013 年: 被引用 99 件2014 年: 被引用 104 件2015 年: 被引用 117 件2016 年: 被引用 142 件2017 年: 被引用 86 件2018 年: 被引用 125 件2019 年: 被引用 532 件2020 年: 被引用 555 件2021 年: 被引用 618 件2022 年: 被引用 423 件2023 年: 被引用 346 件2024 年: 被引用 595 件2025 年: 被引用 163 件2026 年: 被引用 10 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,234 件、この内訳の 31.2%イギリス: 引用元論文 602 件、この内訳の 8.4%フランス: 引用元論文 358 件、この内訳の 5%スペイン: 引用元論文 327 件、この内訳の 4.6%イタリア: 引用元論文 294 件、この内訳の 4.1%カナダ: 引用元論文 271 件、この内訳の 3.8%南アフリカ: 引用元論文 245 件、この内訳の 3.4%ドイツ: 引用元論文 230 件、この内訳の 3.2%スイス: 引用元論文 212 件、この内訳の 3%中国: 引用元論文 207 件、この内訳の 2.9%オーストラリア: 引用元論文 189 件、この内訳の 2.7%オランダ: 引用元論文 165 件、この内訳の 2.3%
0%31.2%その他 25.4%

機関

分野

  • Medicine73.6%
  • Immunology and Microbiology18%
  • Biochemistry, Genetics and Molecular Biology3%
  • Mathematics0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Health Professions0.7%
  • その他2.9%

トピック

  • HIV Research and Treatment13.5%
  • HIV/AIDS drug development and treatment13.1%
  • HIV/AIDS Research and Interventions12%
  • HIV-related health complications and treatments10.6%
  • Immune Cell Function and Interaction3.1%
  • SARS-CoV-2 and COVID-19 Research2.2%
  • その他45.5%

共著者

全論文

検索で開く
  1. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

    著者: Rajesh T. Gandhi, Roger Bedimo, Jennifer Hoy, Raphael J. Landovitz, Davey M. Smith, Ellen Eaton, Clara Lehmann, Sandra A. Springer, Paul E. Sax, Melanie Thompson, Constance A. Benson, Susan Buchbinder, Carlos del Rı́o, Joseph J. Eron, Huldrych F. Günthard, Jean‐Michel Molina, Donna M. Jacobsen, Michael S. Saag - JAMA 2022 被引用: 551

  2. Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

    著者: Paul E. Sax, Kristine M. Erlandson, Jordan E. Lake, Grace A. McComsey, Chloe Orkin, Stefan Eßer, Todd T. Brown, Jürgen K. Rockstroh, Xuelian Wei, Christoph C Carter, Lijie Zhong, Diana M. Brainard, Kathleen Melbourne, Moupali Das, Hans-Jürgen Stellbrink, Frank A. Post, Laura Waters, John R. Koethe - Clinical Infectious Diseases 2019 被引用: 750

  3. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

    著者: Paul E. Sax, Anton Pozniak, Marisa Montes, Ellen Koenig, Edwin DeJesus, Hans-Jürgen Stellbrink, Andrea Antinori, Kimberly Workowski, Jihad Slim, Jacques Reynes, Will Garner, Joseph M. Custodio, Kirsten White, Devi SenGupta, Andrew Cheng, Erin Quirk - The Lancet 2017 被引用: 395

  4. Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials

    著者: Kristine M. Erlandson, Christoph C Carter, Kathleen Melbourne, Todd T. Brown, Cal Cohen, Moupali Das, Stefan Eßer, Hailin Huang, John R. Koethe, Hal Martin, Grace A. McComsey, Chloe Orkin, Frank A. Post, Jürgen K. Rockstroh, Paul E. Sax, Hans‐Jürgen Stellbrink, Laura Waters, Xuelian Wei, Jordan E. Lake - Clinical Infectious Diseases 2021 被引用: 114

  5. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

    著者: Huldrych F. Günthard, Michael S. Saag, Constance A. Benson, Carlos del Rı́o, Joseph J. Eron, Joel E. Gallant, Jennifer Hoy, Michael J. Mugavero, Paul E. Sax, Melanie Thompson, Rajesh T. Gandhi, Raphael J. Landovitz, Davey M. Smith, Donna M. Jacobsen, Paul A. Volberding - JAMA 2016 被引用: 656

  6. Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials

    著者: Paul E. Sax, José Ramón Arribas, Chloe Orkin, Adriano Lazzarin, Anton Pozniak, Edwin DeJesus, Franco Maggiolo, Hans‐Jürgen Stellbrink, Yazdan Yazdanpanah, Rima Acosta, Hailin Huang, Jason T. Hindman, Hal D. Martin, Jared M. Baeten, David A. Wohl - EClinicalMedicine 2023 被引用: 85

  7. Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019

    著者: Sarju Ganatra, Sourbha S. Dani, Javaria Ahmad, Ashish Kumar, Jui Shah, George M. Abraham, Daniel P. McQuillen, Robert M. Wachter, Paul E. Sax - Clinical Infectious Diseases 2022 被引用: 154

  8. Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel

    著者: Paul E. Sax, Melanie Thompson, Michael S. Saag, IAS-USA Treatment Guidelines Panel - JAMA 2024 被引用: 51

  9. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

    著者: Shahin Lockman, Sean S. Brummel, Lauren Ziemba, Lynda Stranix‐Chibanda, Katie McCarthy, Anne Coletti, Patrick Jean‐Philippe, Ben Johnston, Chelsea Krotje, Lee Fairlie, Risa M. Hoffman, Paul E. Sax, Sikhulile Moyo, Nahida Chakhtoura, Jeffrey S. A. Stringer, Gaerolwe Masheto, Violet Korutaro, Haseena Cassim, Blandina T. Mmbaga, Esaú João, Sherika Hanley, Lynette Purdue, Lewis B. Holmes, Jeremiah D. Momper, Roger Shapiro, Navdeep Thoofer, James F. Rooney, Lisa M. Frenkel, K. Rivet Amico, Lameck Chinula, Judith S. Currier, Brookie M. Best, Cheryl Blanchette, Renee Browning, Yao Cheng, Andee Fox, Nagawa Jaliaah, Kevin Knowles, Mark Mirochnick, William Murtaugh, Emmanuel Patras, Mauricio Pinilla, Jean van Wyk, Frances Whalen - The Lancet 2021 被引用: 160

  10. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

    著者: Michael S. Saag, Rajesh T. Gandhi, Jennifer Hoy, Raphael J. Landovitz, Melanie Thompson, Paul E. Sax, Davey M. Smith, Constance A. Benson, Susan Buchbinder, Carlos del Rı́o, Joseph J. Eron, Gerd Fätkenheuer, Huldrych F. Günthard, Jean‐Michel Molina, Donna M. Jacobsen, Paul A. Volberding - JAMA 2020 被引用: 467

  11. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors

    著者: Eric A. Meyerowitz, Aaron Richterman, Rajesh T. Gandhi, Paul E. Sax - Annals of Internal Medicine 2020 被引用: 798

  12. Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials

    著者: Chloe Orkin, Edwin DeJesus, Paul E. Sax, José Ramón Arribas, Samir K. Gupta, Claudia Martorell, Jeffrey L. Stephens, Hans‐Jürgen Stellbrink, David A. Wohl, Franco Maggiolo, Melanie Thompson, Daniel Podzamczer, Debbie Hagins, Jason Flamm, Cynthia Brinson, Amanda Clarke, Hailin Huang, Rima Acosta, Diana M. Brainard, Sean E Collins, Hal Martin - The Lancet HIV 2020 被引用: 136

  13. Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort

    著者: Essy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Mark Thrun, Robert Gottlieb, Daniel R. Kuritzkes, Paul E. Sax, David A. Wohl, Roman Casciano, Paul Hodgkins, Richard Haubrich - Clinical Infectious Diseases 2021 被引用: 123

  14. Two-drug regimens for HIV treatment

    著者: Kevin M Gibas, Sean G. Kelly, José Ramón Arribas, Pedro Cahn, Chloe Orkin, Eric S. Daar, Paul E. Sax, Babafemi Taiwo - The Lancet HIV 2022 被引用: 72

  15. Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel

    著者: Rajesh T. Gandhi, Raphael J. Landovitz, Paul E. Sax, Davey M. Smith, Sandra A. Springer, Huldrych F. Günthard, Melanie Thompson, Roger Bedimo, Constance A. Benson, Susan Buchbinder, Brenda Crabtree‐Ramírez, Carlos del Rı́o, Ellen Eaton, Joseph J. Eron, Jennifer Hoy, Clara Lehmann, Jean‐Michel Molina, Donna M. Jacobsen, Michael S. Saag - JAMA 2024 被引用: 202

  16. Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus

    著者: Paul E. Sax, Jürgen K. Rockstroh, Anne F. Luetkemeyer, Yazdan Yazdanpanah, Douglas Ward, Benoît Trottier, Armin Rieger, Hui Liu, Rima Acosta, Sean E Collins, Diana M. Brainard, Hal Martin, GS-US-380–4030 Investigators - Clinical Infectious Diseases 2020 被引用: 112

  17. Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate

    著者: Samir K. Gupta, Frank A. Post, José Ramón Arribas, Joseph J. Eron, David A. Wohl, Amanda E. Clarke, Paul E. Sax, Hans‐Jürgen Stellbrink, Stefan Eßer, Anton Pozniak, Daniel Podzamczer, Laura Waters, Chloe Orkin, Jürgen K. Rockstroh, Tatiana Mudrikova, Eugènia Negredo, Richard Elion, Susan Guo, Lijie Zhong, Christoph C Carter, Hal Martin, Diana M. Brainard, Devi SenGupta, Moupali Das - AIDS 2019 被引用: 160

  18. Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial

    著者: Hans‐Jürgen Stellbrink, José Ramón Arribas, Jeffrey L. Stephens, Helmut Albrecht, Paul E. Sax, Franco Maggiolo, Catherine Creticos, Claudia Martorell, Xuelian Wei, Rima Acosta, Sean E Collins, Diana M. Brainard, Hal Martin - The Lancet HIV 2019 被引用: 143

  19. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

    著者: Paul E. Sax, David A. Wohl, Michael T. Yin, Frank A. Post, Edwin DeJesus, Michael S. Saag, Anton Pozniak, Melanie Thompson, Daniel Podzamczer, Jean‐Michel Molina, Shinichi Oka, Ellen Koenig, Benoît Trottier, Jaime Andrade‐Villanueva, Gordon Crofoot, Joseph M. Custodio, Andrew Plummer, Lijie Zhong, Huyen Cao, Hal Martin, Christian Callebaut, Andrew Cheng, Marshall W. Fordyce, Scott McCallister - The Lancet 2015 被引用: 598

  20. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

    著者: Michael S. Saag, Constance A. Benson, Rajesh T. Gandhi, Jennifer Hoy, Raphael J. Landovitz, Michael J. Mugavero, Paul E. Sax, Davey M. Smith, Melanie Thompson, Susan Buchbinder, Carlos del Rı́o, Joseph J. Eron, Gerd Fätkenheuer, Huldrych F. Günthard, Jean‐Michel Molina, Donna M. Jacobsen, Paul A. Volberding - JAMA 2018 被引用: 559

  21. Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials

    著者: Jean B. Nachega, Jean-Jacques Parienti, Olalekan A. Uthman, Robert Gross, David W. Dowdy, Paul E. Sax, Joel E. Gallant, Michael J. Mugavero, Edward J. Mills, Thomas P. Giordano - Clinical Infectious Diseases 2014 被引用: 352

  22. Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial

    著者: Chloe Orkin, Kathleen Squires, Jean‐Michel Molina, Paul E. Sax, Otto Sussmann, Gina Lin, Sushma Kumar, George J. Hanna, Carey Hwang, Elizabeth A. Martin, Hedy Teppler - Clinical Infectious Diseases 2020 被引用: 79

  23. Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019

    著者: Dima Dandachi, Grant Geiger, Mary W. Montgomery, Savannah Karmen-Tuohy, Mojgan Golzy, Annukka A.R. Antar, Josep M. Llibre, Maraya Camazine, Alberto Díaz-De Santiago, Philip M. Carlucci, Ioannis M. Zacharioudakis, Joseph Rahimian, Celestine N. Wanjalla, Jihad Slim, Folasade Arinze, Ann Marie Porreca Kratz, Joyce Jones, Shital M. Patel, Ellen Kitchell, Adero Francis, Manoj Ray, David E. Koren, John W. Baddley, B Hill, Paul E. Sax, Jeremy Chow - Clinical Infectious Diseases 2020 被引用: 231

  24. Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases

    著者: Müge Çevik, Chloe Orkin, Paul E. Sax - Open Forum Infectious Diseases 2020 被引用: 52